enfuvirtide
chemical compound
Facts
14 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound
- Has use
- medication
- Active ingredient in
- Fuzeon
- Chemical formula
- C₂₀₄H₃₀₁N₅₁O₆₄
- Defined daily dose
- +0.18
- Has characteristic
- biopharmaceutical
- Isomeric SMILES
- CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- Mass
- +4491.193
- Medical condition treated
- HIV/AIDS, HIV infection
- Pregnancy category
- Australian pregnancy category B2, US pregnancy category B
- Subject has role
- HIV fusion inhibitors, bactericide
- World Health Organisation international non-proprietary name
- 福艾
🏷️ Also known as
en T20
en Fuzeon T-20
en pentafuside
en T 20
en AcTyrThrSerLeuIleHisSerLeuIleGluGluSerGlnAsnGlnGlnGluLysAsnGluGlnGluLeuLeuGluLeuAspLysTrpAlaSerLeuTrpAsnTrpPheNH2
en Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2
en DP178
en enfuvirtide
en Envelope polyprotein GP160 precursor [Contains
en Envelope polyprotein GP160 precursor [Contains: Exterior membrane glycoprotein,GP120, Transmembrane glycoprotein,GP41]
en Exterior membrane glycoprotein,GP120, Transmembrane glycoprotein,GP41]
ar انفوفيرتيد
de Fuzeon
de Enfuvirtid
es enfuvirtide
es Enfuvirtida
fa انفوویرتید
fr 159519-65-0
fr C204H301N51O64
fr Enfurvitide
🔖 Identifiers · 32
- OpenAlex ID
- C2778037500
- ATC code
- J05AX07
- CAB ID
- 145693
- CAS Registry Number
- 159519-65-0
- ChEBI ID
- 608828
- ChEMBL ID
- CHEMBL525076
- ChemSpider ID
- 16743716
- DSSTOX compound identifier
- DTXCID8089163
- DSSTox substance ID
- DTXSID20166672
- DeCS ID
- 57685
- DrugBank ID
- DB00109
- EC number
- 641-385-0
Show all 32 identifiers +20
- ECHA Substance Infocard ID
- 100.169.201
- Freebase ID
- /m/01d4r7
- HSDB ID
- 7341
- IEDB Epitope ID
- 231721
- InChIKey
- PEASPLKKXBYDKL-FXEVSJAOSA-N
- KEGG ID
- D02499
- LiverTox ID
- Enfuvirtide
- MeSH descriptor ID
- D000077560
- MeSH tree code
- D12.644.541.250, D12.776.543.512.500.330.500, D12.776.964.775.325.164.200.500, D12.776.964.775.562.500.200.500, D12.776.964.970.880.325.164.200.500, D12.776.964.970.880.910.330.500, D23.050.327.520.330.500, D12.776.964.350.520.330.500
- MedlinePlus drug identifier
- a603023
- Microsoft Academic ID (discontinued)
- 2778037500
- NDF-RT ID
- N0000148793
- NIAID ChemDB ID
- 059486
- Probes And Drugs ID
- PD071713
- PubChem CID
- 16.2M (16.1M–126.5M, n=3)
- Reaxys registry number
- 11.0M (8.8M–11.4M, n=5)
- RxNorm CUI
- 139896
- SureChEMBL ID
- 34310
- UNII
- 19OWO1T3ZE
- WikiProjectMed ID
- Enfuvirtide
🔗 Connections
Medical condition treated 2
← Drug or therapy used for treatment 2
Has characteristic 1
Has use 1
Subclass of 1
Subject has role 1
Press Enter · cited answer in seconds
0 sources
Summary
enfuvirtide is a type of chemical entity[1]. enfuvirtide is a type of chemical compound[2].
Key Facts
- Chemical formula: C₂₀₄H₃₀₁N₅₁O₆₄[3]
- Has use: medication[4]
- Has characteristic: biopharmaceutical[5]
- Isomeric SMILES: CCC@HC@@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)CC@H[C@@H](C(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)N[C@@H](CCC(=O">[6]
- Mass: 4491.193 dalton[7]
- Medical condition treated: HIV/AIDS[8], HIV infection[9]
- World Health Organisation international non-proprietary name: 福艾[10]
- Subject has role: HIV fusion inhibitors[11], bactericide[12]
- Pregnancy category: Australian pregnancy category B2[13], US pregnancy category B[14]
- Active ingredient in: Fuzeon[15]
- Defined daily dose: 0.18 g[16]
- LiverTox likelihood score: LiverTox toxicity likelihood category E[17]